LicianPro

GT Biopharma, Inc. ·

GTBP 8-K 2026-09-21

GT Biopharma, Inc. (GTBP) 8-K dated 2026-09-21 — accession 0001493152-26-043562.

GT Biopharma, Inc. (GTBP) is a biotechnology company listed on NASDAQ.

GT Biopharma, Inc. filed a 8-K on 2026-09-21. Accession 0001493152-26-043562.

This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Change to holders' rights (Item 3.03), Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GTBP revenue for 2020-12-31 was $0. Net income was -$28.3M. GTBP currently screens at market cap $17.4M.

Not investment advice. The GTBP SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr